These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 668966)
1. [Unspecific, active BCG vaccination therapy in melanoma using a modified scarification procedure]. Wolf M; Menzel W; Keller G Dermatol Monatsschr; 1978 Apr; 164(4):302-3. PubMed ID: 668966 [No Abstract] [Full Text] [Related]
2. Results of adjuvant BCG immunotherapy in malignant melanoma. Wätzig V; Knopf B Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442 [TBL] [Abstract][Full Text] [Related]
3. [Intralesion BCG vaccine therapy in cutaneous melanoma metastasis]. Wolf M; Menzel W Dermatol Monatsschr; 1978 Sep; 164(9):671-2. PubMed ID: 710658 [No Abstract] [Full Text] [Related]
4. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)]. Wätzig V; Knopf B Arch Geschwulstforsch; 1979; 49(2):140-5. PubMed ID: 475550 [TBL] [Abstract][Full Text] [Related]
10. [Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma]. Korting HC; Strasser S; Konz B Hautarzt; 1988 Mar; 39(3):170-3. PubMed ID: 3378889 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms]. Grigorovich NA; Risina DIa; Nodel'son SE Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396 [TBL] [Abstract][Full Text] [Related]
12. [Effect of intra-lesional injection of tuberculin-active protein on metastatic nodules of human malignant melanoma]. Saida T Nihon Hifuka Gakkai Zasshi; 1982 Nov; 92(13):1399-414. PubMed ID: 6984865 [No Abstract] [Full Text] [Related]
13. [Intralesional application of BCG]. Kubíková M; Richter J; Hrivnáková J; Duchková H Cesk Dermatol; 1980 Aug; 55(4):280-1. PubMed ID: 7407971 [No Abstract] [Full Text] [Related]
14. [Immunotherapy of melanoma (proceedings)]. Bolund C Lakartidningen; 1978 Dec; 75(49):4598. PubMed ID: 723350 [No Abstract] [Full Text] [Related]
15. [Effect of intra-tumoral injection of tuberculin-active protein on growth of transplantable mouse melanomas]. Saida T Nihon Hifuka Gakkai Zasshi; 1982 Nov; 92(13):1389-98. PubMed ID: 6984864 [No Abstract] [Full Text] [Related]
16. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma. Dandapat MC; Mohapatra SK; Patra SK Indian J Cancer; 1985 Jun; 22(2):100-7. PubMed ID: 3842124 [No Abstract] [Full Text] [Related]
17. [Side effects of BCG immune therapy in 511 patients with malignant melanoma]. Schult C Hautarzt; 1984 Feb; 35(2):78-83. PubMed ID: 6706581 [TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy of malignant melanomas]. Macher E Haematol Blood Transfus; 1978; 21():285-91. PubMed ID: 738638 [No Abstract] [Full Text] [Related]
19. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin. MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200 [TBL] [Abstract][Full Text] [Related]
20. Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG. Richman SP; Mavligit GM; Wolk R; Gutterman JU; Hersh EM JAMA; 1975 Dec; 234(12):1233-5. PubMed ID: 1242748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]